Schatzberg; Alan F.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Schatzberg; Alan F..The latest application filed is for "administration of fgf9 for treatment of anxiety".

Company Profile

0.11.22

Schatzberg; Alan F. - Los Altos CA US

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Methods for treating depression using NCAM peptide mimetics Grant 9,234,242 - Akil , et al. January 12, 2	2016-01-12
Administration Of Fgf9 For Treatment Of Anxiety App 20140073568 - Akil; Huda ; et al.	2014-03-13
Genetic Polymorphisms Associated With Depression App 20130244990 - Schatzberg; Alan F. ; et al.	2013-09-19
System And Method For Diagnosing And Treating Psychiatric Disorders App 20130102918 - Etkin; Amit ; et al.	2013-04-25
Administration of FGF2 for treamtent of anxiety Grant 8,415,298 - Akil , et al. April 9, 2	2013-04-09
Method to determine the risk for side effects of an SSRI treatment in a person Grant 8,178,299 - Murphy , et al. May 15, 2	2012-05-15
Method to Determine the Risk for Side Effects of an SSRI Treatment in a Person App 20110230469 - MURPHY; GREER M. ; et al.	2011-09-22
Method to determine the risk for side effects of an SSRI treatment in a person Grant 7,951,538 - Murphy , et al. May 31, 2	2011-05-31
Method To Determine The Risk For Side Effects Of An Ssri Treatment In A Person App 20100087421 - MURPHY; GREER M. ; et al.	2010-04-08
Fgf2-related Methods For Diagnosing And Treating Depression App 20090233842 - Akil; Huda ; et al.	2009-09-17
Methods And Compositions For Predicting Compliance With An Antidepressant Treatment Regimen App 20090197276 - Murphy; Greer M. ; et al.	2009-08-06
Methods And Compositions For Predicting Compliance With An Antidepressant Treatment Regimen App 20090191568 - Murphy; Greer M. ; et al.	2009-07-30
Methods for increasing the therapeutic response to electroconvulsive therapy Grant 7,326,697 - Schatzberg , et al. February 5, 2	2008-02-05
Methods and compositions for modulation of sleep cycle App 20070270393 - Buckley; Theresa ; et al.	2007-11-22
Method to determine the risk for side effects of an SSRI treatment in a person App 20060228750 - Murphy; Greer M. ; et al.	2006-10-12
Method to determine the risk for side effects of an SSRI treatment in a person Grant 7,083,921 - Murphy , et al. August 1, 2	2006-08-01
Genes and pathways differentially expressed in bipolar disorder and/or major depressive disorder App 20060051786 - Akil; Huda ; et al.	2006-03-09
Methods and compositions for predicting compliance with an antidepressant treatment regimen App 20050165115 - Murphy, Greer M. ; et al.	2005-07-28
Glucocorticoid blocking agents for increasing blood-brain barrier permeability stan-261con App 20050124533 - Schatzberg, Alan F. ; et al.	2005-06-09
Methods for improving the treatment of major depression by genotyping for the gene for apolipoproteine e4 and for improving the terapeutic response of humans having major depression and carrying the gene for apolipoprotein e4 App 20040106124 - Murphy, Greer M. ; et al.	2004-06-03
Method to determine the risk for side effects of an SSRI treatment in a person App 20040067489 - Murphy, Greer M. ; et al.	2004-04-08
Methods for increasing the therapeutic response to electroconvulsive therapy App 20040029849 - Schatzberg, Alan F. ; et al.	2004-02-12
Methods for treating mild cognitive impairment using a glucocorticoid-specific receptor antagonist App 20040019028 - Schatzberg, Alan F. ; et al.	2004-01-29
Methods for preventing antipsychotic-induced weight gain Grant 6,680,310 - Belanoff , et al. January 20, 2	2004-01-20
Methods of treating mild cognitive impairment using a glucocorticoid-specific receptor antagonist Grant 6,620,802 - Schatzberg , et al. September 16, 2	2003-09-16
Glucocorticoid blocking agents for increasing blood-brain barrier permeability App 20030162695 - Schatzberg, Alan F. ; et al.	2003-08-28
Methods for improving the therapeutic response of humans having major depression and carrying the gene for apolipoprotein E4 App 20030105082 - Murphy, Greer Marechal JR. ; et al.	2003-06-05
Methods for preventing antipsychotic-induced weight gain App 20030027802 - Belanoff, Joseph K. ; et al.	2003-02-06
Glucocorticoid blocking agents for increasing blood-brain barrier permeability App 20020065259 - Schatzberg, Alan F. ; et al.	2002-05-30
Methods for treating psychosis associated with glucocorticoid related dysfunction Grant 6,150,349 - Schatzberg , et al. November 21, 2	2000-11-21

Company Registrations

NCAGE Code	4D9P8	SCHATZBERG, ALAN F
CAGE Code	4D9P8	SCHATZBERG, ALAN F
DUNS	117617303	SCHATZBERG, ALAN F
SEC	0001286029	SCHATZBERG ALAN F

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.